Asset Strategy and Investment /
Branding and Positioning /
Commercial Strategy /
Insight Generation /
Lifecycle Management /
Market Access Strategy /
Market Landscapes /
Patient Journeys /
Pricing /
Value Story Development /
Workshops and Brainstorming /
Case Study: Evaluating global approval and reimbursement for orphan drugs
Problem
Our client, a biotech start-up focused on Orphan Diseases, was building their commercial infrastructure around several key drug launches. They needed to understand which markets offered the best opportunities, while observing a corporate goal to make their products widely available.
Solution
- We worked with the client to establish the breadth and depth of information for each market.
- Our team created standardized formatting for countries, regions, and groups of similar systems.
- We conducted secondary research to provide up to date, useable information per market as well as strategic insights to drive overall commercialization.
Outcome
- Provided key information for planning in 82 countries representing 90% of the global healthcare spend.
- Following this project, the client commissioned several smaller engagements focusing on individual questions, such as product analogues, named patient sales, and reimbursement considerations in specific markets.
